Effectiveness of a multifactorial intervention, consisting of self-management of antihypertensive medication, self-measurement of blood pressure, hypocaloric and low sodium diet, and physical exercise, in patients with uncontrolled hypertension taking 2 or more antihypertensive drugs: The MEDICHY study.

Introduction: High blood pressure is the leading modifiable risk factor for cardiovascular disease, and is associated with high morbidity and mortality and with significant health care costs for individuals and society. However, fewer than half of the patients with hypertension receiving pharmacological treatment have adequate blood pressure control. The main reasons for this are therapeutic inertia, lack of adherence to treatment, and unhealthy lifestyle (i.

Association between nutritional risk based on the NRS-2002 test and hospital morbidity and mortality.

Objective: To analyse the relationship between the presence of malnutrition (MN), as measured by the NRS-2002 nutritional evaluation, and the rate of morbidity and mortality.

Design: Cross-sectional study.

Setting: Patients admitted to Mateu Orfila Hospital, the regional hospital for the island of Menorca, Spain.

[Influence of organizational climate on job satisfaction among health professionals].

Objective: To describe the quality of professional life (QPL) as perceived by primary care workers and to measure the organizational climate (OC). To identify the influence of OC on QPL and the variables that explain this relationship.

Design: Cross-sectional study.

[Division of time in the consultation with the primary care doctor].

Objective: To determine the mean time per meeting--visit--and per problem attended to in the doctor's office and their distribution according to the care procedure during the visit.

Design: Prospective study of the direct encounter in the doctor's office with a third person as timer. SETTING.

[Prescriptions of low therapeutic value imposed on primary care].

Objectives: 1. To quantify the percentage of prescriptions of low therapeutic value, and the associated pharmaceutical expenditure, which the specialist incurs for the general practitioner. 2.